Version: 1.0.0 | Published: 22 Jul 2026 | Updated: 49 days ago
Documentation
Associated Media:
Description:
The study explores whether the availablity of personalised imagery, using three dimensional (3D) digital photography to predict the appearance of the breasts after breast conserving therapy (BTC) for cancer, will better prepare women for surgery and lead to greater satisfication with their outcome.
Consenting women undergoing BCT were assigned at random to one of three groups: receiving standard care (discussion), a 2D photograph, or the 3D simulation before their operation.
Quality of life was assessed using BCT BREAST-Q, including satisfaction with different aspects of their treatment and outcome.
A visual analogue scale (VAS) was used to assess confidence in expectations vs reality of how breasts look.
3D photographs of all study patients taken before and after surgery will improve predictive accuracy of this technique for future patients.
Coverage
Spatial:
United Kingdom
Typical Age Range:
18-250
Follow Up:
1 - 10 Years
Pathway:
Women planning to have breast conserving therapy (BCT) (surgery and
radiotherapy, BCT) identified via two pathways: 1) via the Multi-Disciplinary
Team Meeting (MDM) or 2) the consulting clinician. Group 1 received standard
care only. Group 2 shown photographs of women who have had BCT by a member of
the study team . Group 3 shown a real time simulation of how their own breast is
likely to look after BCT. Participants had baseline 3-D surface image and follow
up images 2weeks, 3M, 6M, 12M and then annually for 5 years post Sx.
Participants completed a BCT BREAST-Q to assess quality of life and satisfaction
with different aspects of their treatment and outcome, and a Visual Analogue
Scale to assess confidence in expectations vs reality of how breasts look. BCT
BREAST-Q and VAS completed pre treatment and at 3M and 12M post treatment.
Provenance
Origin
Purposes:
Study
Sources:
Other
Collection Situations:
Cohort, study, trial
Temporal
Accrual Periodicity:
Static
Distribution Release Date:
09 August 2021
Start Date:
04 May 2017
End Date:
31 March 2025
Time Lag:
Not applicable
Accessibility
Access
Access Rights:
in progress
Access Service:
Although not required, there is an option to use The Royal Marsden’s Trusted
Research Environment and informatics platform: BRIDgE (Biomedical Research
Informatics Digital Environment). BRIDgE is managed by The Royal Marsden’s
Information Team with support by the NIHR Biomedical Research Centre at The
Royal Marsden and ICR. The aim of the platform is to transform clinical practice
and improve outcomes for patients by enabling researchers to access real-world
cancer data within secure, collaborative, cloud-based workspaces. Learn more by
visiting the BRIDgE site within the NIHR BRC area of The Royal Marsden and ICR
website: https://www.cancerbrc.org/BRIDgE
Access Request Cost:
Depends on type of access. Costing available on application.
Delivery Lead Time:
Variable
Jurisdictions:
UK
Data Controller:
Royal Marsden NHS Foundation Trust
Data Processor:
Royal Marsden NHS Foundation Trust
Usage
Data Use Limitations:
Research-specific restrictions
Data Use Requirements:
- Ethics approval required
- Institution-specific restrictions
- User-specific restriction
- Not for profit use
Resource Creators:
The Royal Marsden NHS Foundation Trust; NIHR Biomedical Research Centre at The Royal Marsden and the ICR; Pink Ribbon Foundation
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Conforms To:
LOCAL
Languages:
en